Gilead Sciences
NAS:GILD
Biotechnology
—
MEGA cap
(—)
—
since start of 2022
—
About
BiotechnologyFounded 1987
Gilead Sciences, Inc. is a biopharmaceutical company, which discovers, develops and commercializes therapeutics for unmet medical need. It focuses on human immunodeficiency virus and liver diseases, such as chronic hepatitis C virus infection & chronic hepatitis B virus infection, hematology & oncology, and cardiovascular & inflammation as well as respiratory diseases. The company's products include Descovy, Odefsey, Genvoya, Stribild, Complera, Atripla, Truvada, Viread, Emtriva, Tybost, Vitekta, Vemlidy, Epclusa, Harvoni, Sovaldi, Viread, Hepsera, Zydelig, Letairis, Ranexa, Lexiscan, Cayston, Tamiflu, AmBisome and Macugen. Gilead Sciences was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Headquarters
Executives
Name | Title | Gender |
John F. Milligan, PhD | President, Chief Executive Officer & Director | Male |
Robin L. Washington, MBA, CPA | Chief Financial Officer & Executive Vice President | Female |
Gregg H. Alton | Executive VP-Corporate & Medical Affairs | Male |
John C. Martin, PhD, MBA | Executive Chairman | Male |
Norbert W. Bischofberger, PhD | Chief Scientific Officer & Executive VP-Research | Male |
William A. Lee, PhD | Executive Vice President-Research | Male |
Kevin B. Young | Chief Operating Officer | Male |
Andrew Cheng, MD, PhD | Executive VP-Clinical Research & Development | Male |
Brett A. Pletcher | Secretary, Chief Compliance Officer & Executive VP | Male |
John G. McHutchison, PhD | Executive Vice President-Clinical Research | Male |
Michael L. Riordan | Founder | Male |
Katie L. Watson | Executive Vice President-Human Resources | Female |
Mindful Investing Summary
Gilead Sciences - Competitors and Related Companies
How Gilead Sciences stacks up to its peers in theBiotechnology industry or with competing business segments.
Gilead Sciences
NAS:GILD
Biotechnology
—
MEGA cap
(—)
—
since start of 2022
—
Biogen
NAS:BIIB
Biotechnology
—
MEGA cap
(—)
—
since start of 2022
—
Celgene
NAS:CELG
Biotechnology
—
MEGA cap
(—)
—
since start of 2022
—
Eli Lilly
NYS:LLY
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Johnson & Johnson
NYS:JNJ
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Pfizer
NYS:PFE
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—